| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.DRUDIS.2016.11.015 |
| P698 | PubMed publication ID | 27890820 |
| P2093 | author name string | Karl-Heinz Altmann | |
| Bernhard Pfeiffer | |||
| Maryline Dong | |||
| P2860 | cites work | A new antibiotic kills pathogens without detectable resistance | Q24091299 |
| Diazaquinomycins E-G, novel diaza-anthracene analogs from a marine-derived Streptomyces sp. | Q33808979 | ||
| Elucidation of the Teixobactin Pharmacophore | Q37616543 | ||
| RETRACTED: Targeting Mycobacterial Enzymes with Natural Products | Q38600486 | ||
| Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp. | Q55036785 | ||
| Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination | Q69138212 | ||
| Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, bilogical and biochemical characterization. | Q78418481 | ||
| P433 | issue | 3 | |
| P921 | main subject | natural product | Q901227 |
| tuberculosis | Q12204 | ||
| drug discovery | Q1418791 | ||
| P304 | page(s) | 585-591 | |
| P577 | publication date | 2016-11-24 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | Recent developments in natural product-based drug discovery for tuberculosis | |
| P478 | volume | 22 |
| Q58734819 | Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in : Efficacy and Safety Investigations |
| Q64267833 | Biosynthetic and Synthetic Strategies for Assembling Capuramycin-Type Antituberculosis Antibiotics |
| Q54943520 | Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents. |
| Q59813277 | Protein-protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics |
| Q91025129 | Solution-phase total synthesis of teixobactin |
Search more.